MEDAC PHARMA, INC.. CHICAGO, IL

⚠ NOTE: This page is outdated.
please follow the link.

MEDAC PHARMA, INC., CHICAGO

With a focus on advancing and commercializing therapies for autoimmune diseases and cancer, we strive to use evidence-based medicine to increase the longevity and quality of people’s lives. We have developed a novel methotrexate drug delivery system that has the potential to improve tolerability, increase bioavailability, and enable patients to manage their own therapy. Learn more about this treatment in our product portfolio.

KEY FACTS ABOUT MEDAC PHARMA, INC.

Company name: MEDAC PHARMA, INC.
Status: Active
Filed Number: F14000002378
FEI Number: 455634664
Date of Incorporation: May 28, 2014
Age - 10 years
Home State: DE
Company Type: Foreign for Profit

CONTACTS

Website: http://medacpharma.com
Phones: (855) 336-3322
(312) 854-0500
(312) 750-1082

MEDAC PHARMA, INC. NEAR ME

Principal Address: 29 N. WACKER DR., SUITE 704,
CHICAGO,
IL,
60606

Officers and Directors

The MEDAC PHARMA, INC. managed by the three persons from CHICAGO on following positions: AUTH, President, DIRE

Luyan Li

Position: AUTH Active
From: CHICAGO, IL, 60606

Mary T Shoemaker

Position: President Active
From: CHICAGO, IL, 60606

Nikolaus G Stolberg

Position: DIRE Active
From: CHICAGO, IL, 60606

Registered Agent is CORPORATION SERVICE COMPANY

Address: 1201 HAYS STREET, TALLAHASSEE, FL, 32301, 2525

Events

March 12, 2019: NAME CHANGE AMENDMENT

November 18, 2014: AMENDMENT

Annual Reports

2018: January 9, 2018
2017: April 25, 2017

MEDAC PHARMA, INC. CHICAGO, IL